Glenn Coleman

Filings by Glenn Coleman span 5 companies, the busiest being Integra Lifesciences Holdings Corp, Curtiss Wright Corp and DENTSPLY SIRONA Inc. Between 17 November 2008 and 30 September 2026, the trades on record add up to 157 filings.

The open-market side counts 3 purchases for €284k alongside 36 sales for €8.0M. On balance, insiders were net sellers of €7.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 108 share grants and 8 option exercises. In 2026 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €9,457 and half below.

The record was last updated on 2 October 2026 with an open-market purchase (€2,622) in Charles River Laboratories International, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.